| Released | Contributor | Author | Title | Pages | Price |
|---|
| Jun 17, 2013 | New Constructs, LLC | N/A | CORT: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | Jun 17, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-drugs | 18 | $207 | | Jun 14, 2013 | S&P Capital IQ Quantitative Report | N/A | Corcept Therapeutics | 6 | $69 | | Jun 14, 2013 | Pechala's Reports | Frantisek Pechala | CORCEPT THERAPEUTICS INC (CORT) 12-months forecast | 1 | $15 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (Global) | 105 | $1207.50 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (North America) | 78 | $897 | | Jun 13, 2013 | Wright Reports | N/A | Wright Industry Averages: Pharmaceuticals & Biotechnology (United States) | 77 | $885.50 | | Jun 13, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: APRI , CORT , ELTP , GALT , MNOV , RGRX -- DRUGS | 3 | $34.50 | | Jun 13, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: CORCEPT THERAPEU -- CORT | 1 | $11.50 | | Jun 12, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for CORT | 11 | $126.50 |
|
View All Reports for CORT ... |
|
|
0.02(1.10%) 4:00PM EDT